title: Comment on: "pharmacokinetics and tolerability of the novel oral prostacyclin IP receptor agonist selexipag".
authors: Suramus Bio, Drug Development, 29th main, 10th cross, JP Nagar I Phase, Bangalore, 560078, India. srini.suramus@yahoo.com.
authors: Nuggehally R
authors: NR
authors: Srinivas
mesh_terms: D000081:Acetamides / Q000008:administration & dosage*; D000085:Acetates / Q000493:pharmacokinetics*; D018565:Food-Drug Interactions; D006801:Humans; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D044006:Receptors, Epoprostenol / Q000819:agonists*
chemical_list: D000081:Acetamides; D000085:Acetates; D011719:Pyrazines; D044006:Receptors, Epoprostenol